In a Q&A, Citeline's Claire Riches discusses AI use in choosing trial endpoints and testing protocol feasibility. She also addresses data for enrollment planning and says sponsors may underestimate how accessible these tools are.
Why it matters: The discussion covers sponsors' trial design and enrollment planning activities.
Technology and AI in trialsTrial conduct and operationsAI summary
Read at Applied Clinical Trials